We used markers of renal function as the example outcomes because Akamine et al. (11) have already reported on the relationship between blood NfL concentration and renal function in healthy individuals (based on serum NfL) and patients with diabetes mellitus (based on plasma NfL). This evidence concerns the gene NEFL and diabetes mellitus.